drugset / Trial / NCT01742429
Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
To test the efficacy of 14 day levofloxacin and bismuth-containing second-line therapy for resistant Helicobacter pylori infection, to compare with the classical quadruple therapy.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | — | — |
| Subject | Levofloxacin | Small molecule | — | — |
| Comparator | Metronidazole | Small molecule | — | — |
| Comparator | Tetracycline | Unknown | — | — |
| Background | Bismuth subsalicylate | Small molecule | — | — |
Indications
No indication recorded.